This week's Fierce Biotech is brought to you by InterVenn Biosciences.

Webinar: Glycoproteomic Biomarkers in the Clinic: How InterVenn Is Powering the Development of Predictive Biomarkers for Therapeutic Response

Scientists have long searched for biomarkers to predict therapeutic responses using traditional genomic sequencing and other omic approaches, but clinically useful tools remain out of reach for most patients.

Join our webinar to learn how targeted glycoproteomic services are driving new clinical breakthroughs. Dr. David Braun will share exciting findings from the Checkmate 9ER trial, presented at ESMO last year, and explore how glycoproteomic analysis could unlock powerful prognostic and predictive biomarkers.